Other Cannabinoids
Other Cannabinoid Agonists |
|
|---|---|
| Cat. No. | Product Name / Activity |
| 1445 | N-Arachidonylglycine |
| GPR18 agonist; endocannabinoid | |
Other Cannabinoid Antagonists |
|
| Cat. No. | Product Name / Activity |
| 6372 | PSB CB5 |
| Selective GPR18 antagonist | |
Other Cannabinoid Inhibitors |
|
| Cat. No. | Product Name / Activity |
| 1462 | AACOCF3 |
| FAAH inhibitor | |
| 3262 | JNJ 1661010 |
| Selective, reversible FAAH inhibitor | |
| 4715 | JZL 195 |
| Dual FAAH and MAGL inhibitor | |
| 4175 | PF 3845 |
| Selective FAAH inhibitor | |
| 5209 | TAK 21d |
| Potent FAAH inhibitor | |
| 4355 | TC-F 2 |
| Potent, reversible and selective FAAH inhibitor | |
| 4612 | URB 597 |
| Potent and selective FAAH inhibitor | |
| 3252 | WWL 70 |
| Potent ABHD6 inhibitor | |
Other |
|
| Cat. No. | Product Name / Activity |
| 2288 | O-1918 |
| Silent antagonist for putative abnormal-CBD (Cat. No. 1297) receptor | |
| 0879 | Palmitoylethanolamide |
| FAAH and PAA substrate. Selective GPR55 agonist | |
Neurodegeneration Research Product Guide
Our Neurodegeneration guide highlights over 275 products for neurodegeneration research.
Request copyRequest PDFPain Research Product Guide
Our Pain guide highlights over 280 products for Pain research.
Request copyRequest PDFCannabinoid Scientific Review
Our Cannabinoid review gives an overview of the pharmacological ligands used to study the cannabinoid CB1 and CB2 receptors.
Request copyRequest PDF